[HTML][HTML] Advanced glycation end products and oxidative stress in type 2 diabetes mellitus

K Nowotny, T Jung, A Höhn, D Weber, T Grune - Biomolecules, 2015 - mdpi.com
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease
characterized by insulin resistance and β cell failure leading to elevated blood glucose …

Advanced glycation endproducts in food and their effects on health

MW Poulsen, RV Hedegaard, JM Andersen… - Food and Chemical …, 2013 - Elsevier
Advanced glycation endproducts (AGEs) form by Maillard-reactions after initial binding of
aldehydes with amines or amides in heated foods or in living organisms. The mechanisms of …

Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

H Vlassara, J Uribarri - Current diabetes reports, 2014 - Springer
Despite new and effective drug therapies, insulin resistance (IR), type 2 diabetes mellitus
(T2D) and its complications remain major medical challenges. It is accepted that IR, often …

The role of dietary advanced glycation end products in metabolic dysfunction

D Sergi, H Boulestin, FM Campbell… - Molecular Nutrition & …, 2021 - Wiley Online Library
Advanced glycation end products (AGEs) are a heterogeneous group of molecules
produced, non‐enzymatically, from the interaction between reducing sugars and the free …

Molecular biology of atherosclerosis

PN Hopkins - Physiological reviews, 2013 - journals.physiology.org
At least 468 individual genes have been manipulated by molecular methods to study their
effects on the initiation, promotion, and progression of atherosclerosis. Most clinicians and …

Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1

W Cai, M Ramdas, L Zhu, X Chen… - Proceedings of the …, 2012 - National Acad Sciences
The epidemics of insulin resistance (IR) and type 2 diabetes (T2D) affect the first world as
well as less-developed countries, and now affect children as well. Persistently elevated …

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

J Uribarri, W Cai, M Ramdas, S Goodman… - Diabetes …, 2011 - Am Diabetes Assoc
OBJECTIVE Increased oxidative stress (OS) and impaired anti-OS defenses are important in
the development and persistence of insulin resistance (IR). Several anti-inflammatory and …

AGE restriction in diabetes mellitus: a paradigm shift

H Vlassara, GE Striker - Nature Reviews Endocrinology, 2011 - nature.com
Persistently elevated oxidative stress and inflammation precede or occur during the
development of type 1 or type 2 diabetes mellitus and precipitate devastating complications …

Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes

S Yamagishi - Experimental gerontology, 2011 - Elsevier
A non-enzymatic reaction between ketones or aldehydes and the amino groups of proteins,
lipids and nucleic acids contributes to the aging of macromolecules and to the development …

Proinflammation: the key to arterial aging

M Wang, L Jiang, RE Monticone, EG Lakatta - Trends in Endocrinology & …, 2014 - cell.com
Arterial aging is the major contributing factor to increases in the incidence and prevalence of
cardiovascular disease, due mainly to the presence of chronic, low-grade,'sterile'arterial …